InvestEU - EIB venture debt for bone therapy innovator Novadip
The EIB has signed an €18 million venture debt deal with Belgian biotech company Novadip funding innovation on its therapies for rare bone-related genetic diseases. Novadip will further develop its unique bone tissue regeneration platform to create new solutions for patients with limited or no effective treatment options. The agreements were made possible with the support of the InvestEU Programme, which aims to trigger more than €372 billion in additional investment between 2021 and 2027. The European Investment Bank (EIB) and Novadip have signed a €18